Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3102 ARTÍCULOS , VIENDO DEL 1666 AL 1680

2-Hydroxy-3-isobutyl-9-[(11)C]methoxy-10-methoxy-1,2,3,4,6,7,-hexahydro-11bH-bezo[α]-quinolizine

Leung K.

2006 Mar 17 [updated 2010 Oct 27]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013.

Assessment of fall-related self-efficacy and activity avoidance in people with Parkinson's disease

Nilsson MH, Drake AM, Hagell P.

BMC Geriatr. 2010 Oct 25;10:78. doi: 10.1186/1471-2318-10-78.

Cardiac denervation in rapid eye movement sleep behavior disorder and Parkinson's disease: getting to the heart of the matter

Siderowf A, Jennings D.

Mov Disord. 2010 Oct 30;25(14):2269-71. doi: 10.1002/mds.23404.

Long-term stability of effects of subthalamic stimulation in Parkinson's disease: Indian Experience

Kishore A, Rao R, Krishnan S, Panikar D, Sarma G, Sivasanakaran MP, Sarma S.

Mov Disord. 2010 Oct 30;25(14):2438-44. doi: 10.1002/mds.23269.

[Gene therapy for Parkinson disease]

Muramatsu S.

Nihon Rinsho. 2010 Aug;68 Suppl 8:646-9.

Bromocriptine: old drug, new formulation and new indication

Holt RI, Barnett AH, Bailey CJ.

Diabetes Obes Metab. 2010 Dec;12(12):1048-57. doi: 10.1111/j.1463-1326.2010.01304.x.

[Rasagiline: effectiveness and protection in Parkinson's disease]

Pagonabarraga J, Kulisevsky J.

Rev Neurol. 2010 Nov 1;51(9):535-41.

[Speech and voice disorders in Parkinson's disease]

Martnez-Sánchez F.

Rev Neurol. 2010 Nov 1;51(9):542-50.

Night-time bioavailability of levodopa/carbidopa/entacapone is higher compared to controlled-release levodopa/carbidopa

Kuoppamäki M, Sauramo A, Korpela K, Vahteristo M, Kailajärvi M, Lehtinen T, Ellmén J.

Int J Clin Pharmacol Ther. 2010 Nov;48(11):756-60. doi: 10.5414/cpp48756.

AFFITOME® technology in neurodegenerative diseases: the doubling advantage

Schneeberger A, Mandler M, Mattner F, Schmidt W.

Hum Vaccin. 2010 Nov;6(11):948-52. doi: 10.4161/hv.6.11.13217. Epub 2010 Nov 1.

Stem cell-based biological tooth repair and regeneration

Volponi AA, Pang Y, Sharpe PT.

Trends Cell Biol. 2010 Dec;20(12):715-22. doi: 10.1016/j.tcb.2010.09.012. Epub 2010 Oct 28.

Synergistic effects of environmental risk factors and gene mutations in Parkinson's disease accelerate age-related neurodegeneration

Peng J, Oo ML, Andersen JK.

J Neurochem. 2010 Dec;115(6):1363-73. doi: 10.1111/j.1471-4159.2010.07036.x. Epub 2010 Nov 4.

Deep brain stimulation mechanisms: beyond the concept of local functional inhibition

Deniau JM, Degos B, Bosch C, Maurice N.

Eur J Neurosci. 2010 Oct;32(7):1080-91. doi: 10.1111/j.1460-9568.2010.07413.x.

Restoration of locomotive function in Parkinson's disease by spinal cord stimulation: mechanistic approach

Fuentes R, Petersson P, Nicolelis MA.

Eur J Neurosci. 2010 Oct;32(7):1100-8. doi: 10.1111/j.1460-9568.2010.07417.x.

Total knee arthroplasty and Parkinson disease: enhancing outcomes and avoiding complications

Macaulay W, Geller JA, Brown AR, Cote LJ, Kiernan HA.

J Am Acad Orthop Surg. 2010 Nov;18(11):687-94. doi: 10.5435/00124635-201011000-00006.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias